A detailed history of Optimum Investment Advisors transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Optimum Investment Advisors holds 240 shares of TEVA stock, worth $5,380. This represents 0.0% of its overall portfolio holdings.

Number of Shares
240
Previous 240 -0.0%
Holding current value
$5,380
Previous $3,000 33.33%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 03, 2023

SELL
$7.2 - $9.47 $20,160 - $26,516
-2,800 Reduced 92.11%
240 $1,000
Q1 2023

May 03, 2023

BUY
$8.36 - $11.37 $6,688 - $9,096
800 Added 35.71%
3,040 $26,000
Q4 2022

Jan 05, 2023

BUY
$7.95 - $9.48 $15,900 - $18,960
2,000 Added 833.33%
2,240 $0
Q4 2020

Jan 21, 2021

SELL
$8.61 - $11.04 $4,305 - $5,520
-500 Reduced 67.57%
240 $2,000
Q3 2020

Oct 06, 2020

SELL
$8.57 - $12.69 $3,428 - $5,076
-400 Reduced 35.09%
740 $7,000
Q2 2020

Jul 16, 2020

SELL
$8.12 - $13.12 $8,119 - $13,120
-1,000 Reduced 46.73%
1,140 $14,000
Q1 2020

Apr 21, 2020

BUY
$6.69 - $13.45 $2,676 - $5,380
400 Added 22.99%
2,140 $19,000
Q4 2019

Jan 22, 2020

SELL
$6.53 - $10.72 $653 - $1,072
-100 Reduced 5.43%
1,740 $17,000
Q3 2019

Oct 17, 2019

SELL
$6.16 - $9.6 $6,856 - $10,684
-1,113 Reduced 37.69%
1,840 $13,000
Q1 2019

May 03, 2019

SELL
$15.58 - $20.01 $3,116 - $4,002
-200 Reduced 6.34%
2,953 $46,000
Q4 2018

Feb 04, 2019

SELL
$14.59 - $23.84 $5,471 - $8,940
-375 Reduced 10.63%
3,153 $49,000
Q3 2018

Oct 05, 2018

SELL
$21.06 - $25.65 $7,918 - $9,644
-376 Reduced 9.63%
3,528 $76,000
Q1 2018

May 09, 2018

BUY
$16.68 - $22.07 $65,118 - $86,161
3,904 New
3,904 $67,000
Q3 2017

Nov 21, 2017

SELL
$15.41 - $32.17 $133,111 - $277,884
-8,638 Closed
0 $0
Q2 2017

Aug 14, 2017

BUY
N/A
8,638
8,638 $287,000

Others Institutions Holding TEVA

About TEVA PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $24.9B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Optimum Investment Advisors Portfolio

Follow Optimum Investment Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Optimum Investment Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Optimum Investment Advisors with notifications on news.